Summary Marketline’s MedImmune LLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by MedImmune LLC since January2007.
Synopsis Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.
Key Highlights This report includes MedImmune LLC’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.
The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by MedImmune LLC. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.
Scope - Provides intelligence on MedImmune LLC’s M&A, strategic partnerships and alliances, capital raising and private equity transactions. - Detailed reports of various financial transactions undertaken by MedImmune LLC and its subsidiaries since 2007. - Information about key financial and legal advisors for MedImmune LLC’s financial deals transactions. - Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.
Reasons to buy - Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances. - Form an independent opinion about MedImmune LLC’s growth strategies through the organic and inorganic activities undertaken since 2007. - Track your competitors’ business structure and growth strategies.
Our reports have been used by over 10K customers, including:
Interleukin 1 (IL1) - Drugs in Development, 2021 Summary According to the recently published report ’Interleukin 1 - Drugs in Development, 2021’; Interleukin 1 (IL1) pipeline Target constitutes close to 36 molecules. Out of which approximately 35 molecules are developed by companies and remaining...
The Global Pharmaceutical CDMO Market was valued USD 160.12 billion in 2020, and it is expected to reach USD 236.61 billion by 2026, registering a CAGR of 6.5%, during the period of forecast period (2021-2026). The CMO/CDMO service sector is uniquely positioned to address some of the challenges that drug developers are facing amid the COVID-19...
200 pages •
By The Business Research Company
• Mar 2021
Major players in the analytical standards market are Merck KGaA, Agilent Technologies, Waters Corporation, LGC Standards, PerkinElmer Inc, Restek Corporation, SPEX CertiPrep, AccuStandard Inc., Thermo Fisher Scientific Inc, and Mallinckrodt. The global analytical standards market is expected to grow from $1.34 billion in 2020 to $1.52...
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global IV and Oral Iron Drugs Market Report
The global IV and oral iron drugs market by revenue is expected to grow at a CAGR of 11.6% during the period 2021–2026.
The global IV and oral iron drugs market is expected to grow due to the prevalence...
Left Ventricular Dysfunction (Cardiovascular) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Left Ventricular Dysfunction - Drugs in Development, 2021, provides an overview of the Left Ventricular Dysfunction (Cardiovascular) pipeline landscape. Left...
The APS software market was valued at US$ 1,491.22 million in 2020 and is projected to reach US$ 2,941.27 million by 2028; it is expected to grow at a CAGR of 9.0% from 2021 to 2028. The global APS software market is segmented into five major regions—North America, Europe, Asia Pacific (APAC), the Middle East and Africa (MEA), and South...
547 pages •
By Global Industry Analysts
• Apr 2021
- The global market for Refined Glycerin is forecast to reach 8.1 billion pounds by 2022, driven by the growing preference for renewable feedstocks as against petroleum derived feedstocks and fairly encouraging business climate in all major end-use application sectors like food and pharma which continue to grow...
The mass spectrometry market size is expected to grow from an estimated USD 4.1 billion in 2020 to USD 5.6 billion by 2025, at a CAGR of 6.5%. Increasing spending on pharmaceutical R&D across the globe, government regulations on drug safety, growing focus on the quality of food products, increase in crude and shale gas production, and growing...
Belgium - Healthcare, Regulatory and Reimbursement Landscape
The analyst has released its latest report: “Belgium - Healthcare, Regulatory and Reimbursement Landscape”.The report is an essential source of information on analysis of healthcare, regulatory, and reimbursement landscape in...
The protein A resin market is expected to reach USD 1.9 billion by 2025 from USD 1.1 billion in 2020, at a CAGR of 11.4% during the forecast period. The protein A resin market has witnessed increasing consumption due to increased monoclonal antibody production on account of the pandemic situation worldwide.. Growth in the market can primarily...
Gross Domestic Expenditure On R&D
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.